8 min listen
Richard Horton on the Oxford vaccine phase 3 trial
Richard Horton on the Oxford vaccine phase 3 trial
ratings:
Length:
12 minutes
Released:
Dec 8, 2020
Format:
Podcast episode
Description
Editor-in-chief of The Lancet, Richard Horton, discusses the results of the Oxford vaccine's phase 3 trial.
Released:
Dec 8, 2020
Format:
Podcast episode
Titles in the series (100)
The Lancet: September 08, 2006 by The Lancet in conversation with